Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Zenas BioPharma, Inc. (ZBIO) had Earnings per Share (EPS) (Basic) of $-0.80 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$10.00M |
|
$-33.57M |
|
-- |
|
$10.00M |
|
$47.33M |
|
$-37.33M |
|
$3.55M |
|
$-33.78M |
|
$-33.78M |
|
$-33.57M |
|
$-33.57M |
|
$-33.57M |
|
$-33.57M |
|
$-37.33M |
|
$-37.31M |
|
41.80M |
|
41.80M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.80 |
$-0.80 |
|
| Balance Sheet Financials | |
$317.81M |
|
$0.07M |
|
$15.96M |
|
$333.77M |
|
$49.13M |
|
-- |
|
$0.32M |
|
$49.45M |
|
$284.32M |
|
$284.32M |
|
$284.32M |
|
41.82M |
|
| Cash Flow Statement Financials | |
$-37.05M |
|
$-86.27M |
|
$0.10M |
|
$319.83M |
|
$196.55M |
|
$-123.28M |
|
$5.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-373.30% |
|
-373.30% |
|
-- |
|
-337.78% |
|
-335.73% |
|
$-37.07M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-11.81% |
|
-11.81% |
|
-10.06% |
|
-11.81% |
|
$6.80 |
|
$-0.89 |
|
$-0.89 |
|